Vorinostat
Vorinostat | |
---|---|
Term | Vorinostat |
Short definition | Vorinostat - (pronounced) (before-IN-oh-stat) drug used to treat cutaneous T-cell lymphoma that has come back, worsened, or failed to improve during or after treatment with two systemic therapies. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Vorinostat - (pronounced) (before-IN-oh-stat) drug used to treat cutaneous T-cell lymphoma that has come back, worsened, or failed to improve during or after treatment with two systemic therapies. It is also being studied in the treatment of other types of cancer. Vorinostat blocks certain enzymes needed for cell division and can kill cancer cells. It's a type of histone deacetylase inhibitor. Also called SAHA, Suberoylanilide Hydroxamic Acid and Zolinza
External links
- Medical encyclopedia article on Vorinostat
- Wikipedia's article - Vorinostat
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski